The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals
Open accessAbstract
Background: The prevalence and impact of inappropriate empiric antibiotic therapy for bloodstream infections (BSI) is unclear. We aimed to determine the population-level burden, predictors, and mortality risk of in vitro susceptibility-discordant empiric antibiotic therapy (DEAT) among BSI patients. Methods: Inpatients with BSI treated with systemic antibiotics on the day blood cultures were drawn or the following day were identified. DEAT occurred if the isolate was not susceptible in vitro to antibiotic(s) administered on blood culture sampling day. DEAT prevalence by hospital type was calculated using regression tree analysis and predictors were identified using Generalized Estimating Equations. Adjusted odds ratio (aOR) of in-hospital mortality was determined using logistic regression. Findings: At 131 hospitals between 2005–2014, 26,036 assessable BSI patients received empiric therapy on the day of or day after first blood culture collection. Seventeen percent (4,428) received no antibiotics on blood culture day. Of the remaining 21,608 patients, 4,165(19–3%) received DEAT [reliability-adjusted range by hospital type: 16·6(95% CI, 15·0–18·5)% to 21·1(95% CI, 20·1–22·1)%]. Antibiotic-resistant phenotypes strongly predicted DEAT [a0R=9·09(95% CI, 7·68–10·76);p<0·001]. Most DEAT events (73%) and associated deaths (76·8%) occurred among patients with S. aureus and Enterobacteriaceae BSIs. DEAT was independently associated with higher mortality (aOR=1·5[95% CI, 1·4–1·7];p<0·001), a relationship that was unaffected by the presence or absence of resistance or sepsis or septic shock. Interpretation: Approximately one in five BSI patients in U.S. hospitals received DEAT, which was closely associated with antibiotic-resistant pathogens. DEAT decreased survival even among those presenting without sepsis. Earlier identification of bloodstream pathogens and resistance is likely to improve population-level outcomes. Funding: NIH, U.S. CDC, AHRQ
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61602-x · Cited by 21,320
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225
The R Package geepack for Generalized Estimating Equations
Halekoh, U., Højsgaard, S., & Yan, J. (2006) · Journal of Statistical Software · doi:10.18637/jss.v015.i02 · Cited by 1,907
Bell, B. G., Schellevis, F., Stobberingh, E., Goossens, H., & Pringle, M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-13 · Cited by 1,262
The R Package geepack for Generalized Estimating Equations
Højsgaard, S., Halekoh, U., & Yan, J. (2005) · RePEc: Research Papers in Economics · Cited by 805
Harris, P. N. A., Tambyah, P. A., Lye, D. C., Mo, Y., Lee, T. H., Yilmaz, M., Alenazi, T. H., Arabi, Y., Falcone, M., Bassetti, M., et al. (2018) · JAMA · doi:10.1001/jama.2018.12163 · Cited by 774
Cited by
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab1013 · Cited by 519
Van Heuverswyn, J., Valik, J. K., Desirée van der Werff, S., Hedberg, P., Giske, C., & Nauclér, P. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac727 · Cited by 163
Blood culture-free ultra-rapid antimicrobial susceptibility testing
Kim, T. H., Kang, J., Jang, H., Joo, H., Lee, G. Y., Kim, H., Cho, U., Bang, H., Jang, J., Han, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07725-1 · Cited by 90
MacVane, S. H., & Dwivedi, H. P. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae282 · Cited by 36
Ohnuma, T., Chihara, S., Costin, B., Treggiari, M., Bartz, R. R., Raghunathan, K., & Krishnamoorthy, V. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005870 · Cited by 35
Metadata
- Authors
- Kadri, S. S., Lai, Y. L., Warner, S., Strich, J. R., Babiker, A., Ricotta, E. E., Demirkale, C. Y., Dekker, J. P., Palmore, T. N., Rhee, C., Klompas, M., Hooper, D. C., Powers, J. H., Srinivasan, A., Danner, R. L., & Adjemian, J.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 21
- Issue
- 2
- Pages
- 241-251
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W3083892815
- Cited by
- 279
- References
- 34
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. https://app.cochat.ai/papers/10.1016/s1473-3099(20)30477-1
- The paper
- Kadri, S. S., Lai, Y. L., Warner, S., Strich, J. R., Babiker, A., Ricotta, E. E., Demirkale, C. Y., Dekker, J. P., Palmore, T. N., Rhee, C., Klompas, M., Hooper, D. C., Powers, J. H., Srinivasan, A., Danner, R. L., & Adjemian, J. (2021). Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(20)30477-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.